D. Overbosch
About
In The Last Decade
D. Overbosch
53 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 116
- Public Health, Environmental and Occupational Health 882
- Hepatology 223
- Parasitology 194
- Infectious Diseases 169
- Pediatrics, Perinatology and Child Health 121
Countries citing papers authored by D. Overbosch
This map shows the geographic impact of D. Overbosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Overbosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Overbosch more than expected).
Fields of papers citing papers by D. Overbosch
This network shows the impact of papers produced by D. Overbosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Overbosch. The network helps show where D. Overbosch may publish in the future.
Co-authorship network of co-authors of D. Overbosch
This figure shows the co-authorship network connecting the top 25 collaborators of D. Overbosch. A scholar is included among the top collaborators of D. Overbosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Overbosch. D. Overbosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 37 | |
| 3 | 35 | |
| 4 | 6 | |
| 5 | [Availability of antimalarial agents in Dutch hospitals]. | 1 |
| 6 | 25 | |
| 7 | 26 | |
| 8 | 9 | |
| 9 | 29 | |
| 10 | 22 | |
| 11 | 54 | |
| 12 | 2 | |
| 13 | 287 | |
| 14 | 35 | |
| 15 | 103 | |
| 16 | [Cholestatic hepatitis ascribed to the use of thiabendazole]. | 4 |
| 17 | Inhibitory effects of cimetidine ketoconazole and miconazole on the metabolism of praziquantel. | 10 |
| 18 | 67 | |
| 19 | 19 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.